摘要
目的完整结肠系膜切除术在老年人结肠癌手术治疗中的安全性分析。方法选取2021年10月—2023年5月本院接收的罹患结肠癌的老年患者78例为研究对象,按照随机抽签法分为对照组和实验组,每组39例。其中,传统结肠癌根治术治疗用于对照组,完整结肠系膜切除术治疗用于实验组,就两组手术治疗效果展开比较。结果两组老年人结肠癌患者术后出血量和淋巴结清除数比较,实验组术后出血量比对照组少,实验组淋巴结清除数比对照组多(P<0.05);两组患者并发症和结肠癌疾病复发率比较,实验组并发症和复发率均低于对照组(P<0.05);两组患者术后一年生存率和三年生存率比较,实验组均高于对照组(P<0.05);患者术后生活质量评分比较,实验组均高于对照组(P<0.05)。结论在老年人结肠癌手术治疗中,完整结肠系膜切除术是具有显著疗效,治疗过程中达到治疗疾病目的同时,减轻对于患者造成的手术伤害,在临床针对老年人结肠癌治疗具有广泛推广可行性。
Objective To analyze safety of complete mesocolon resection in surgical treatment of elderly with colon cancer.Methods The paper chose elderly patients with colon cancer from October 2021 to May 2023 As reference subjects and divided them into groups with guiding principle of random drawing,with specific groups of control group and experimental group.the number of cases of colon cancer in two groups was 78,and number of samples in each group was 39.Among them,control group was treated with traditional radical resection of colon cancer,and experimental group with complete mesocolon resection.Surgical treatment effect between two groups was compared.Results Comparison of postoperative bleeding and lymph node clearance between two groups showed experimental group had less postoperative bleeding,and more lymph node clearance than control group(P<0.05).Comparison of complications and recurrence rates between two groups showed experimental group had lower complications and recurrence rates than control group(P<0.05).1-year and 3-year survival rates between two groups after surgery comparison showed,those of experimental group were higher than control group(P<0.05).Postoperative life quality scores of experimental group were higher than control group(P<0.05).Conclusion During surgical treatment of elderly with colon cancer,complete mesocolon resection can achieve significant curative effect,can reduce surgical damage for patients and achieve goal of disease treatment,which is feasible to widely promote for elderly with colon cancer in clinical practice.
作者
尚大可
高满仓
赵力波
陈豪
于晓函
SHANG Dake;GAO Mancang;ZHAO Libo;CHEN Hao;YU Xiaohan(General Surgery Department,China Aerospace Science and Industry Corporation No.731 Hospital,Beijing 100074)
出处
《智慧健康》
2023年第27期163-166,共4页
Smart Healthcare
